Block, S.L., Vesikari, T., Goveia, M.G., Rivers, S.B., Adeyi, B.A., Dalla, M.J., et al. (2007) Pentavalent Rotavirus Vaccine Dose Confirmation Efficacy Study Group. Efficacy, Immunogenicity, and Safety of a Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine at the end of Shelf Life. Pediatrics, 119, 11-18.
https://doi.org/10.1542/peds.2006-2058

has been cited by the following article:

• TITLE: Molecular Characterization of Rotavirus Strains Circulating in Enugu Nigeria: 2011 to 2016

  AUTHORS: B. N. Tagbo, C. Chukwubike, J. M. Mwenda, M. L. Seheri, G. Armah, J. M. Mphahlele, U. C. Ozumba, C. Benjamin-Puja, C. Azubuike, H. U. Okafor, R. O. Nnani, V. Okafor, B. O. Edelu, C. B. Eke, O. Udemba, A. Isiaka, L. Namadi, N. Umezinne, R. Njoku, C. Odume, V. Osaro, N. Ogude, M. U. Okwesili, S. K. Ezebilo, K. M. Yusuf, E. O. Obidike, ICH UNTH Enugu Rotavirus Group

  KEYWORDS: Rotavirus, Molecular Characterization, Children, Genotype

  JOURNAL NAME: World Journal of Vaccines, Vol.9 No.1, February 20, 2019

  ABSTRACT: Rotavirus gastroenteritis is a major public health concern globally, estimated to cause 215,000 deaths among children